Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.13
Debt to EBITDA (avg)
0.38
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.86
Tax Ratio
24.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.60%
ROCE (avg)
29.97%
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
62
Industry P/E
32
Price to Book Value
15.16
EV to EBIT
45.23
EV to EBITDA
38.23
EV to Capital Employed
15.31
EV to Sales
7.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
33.85%
ROE (Latest)
24.61%
Loading Valuation Snapshot...
8What is working for the Company
PBDIT(Q)
Highest at Rs 83.16 cr.
PBT LESS OI(Q)
Highest at Rs 72.05 cr.
PAT(Q)
Highest at Rs 55.53 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 24.29%
-1What is not working for the Company
EPS(Q)
Lowest at Rs 6.74
Loading Valuation Snapshot...
Here's what is working for Corona Remedies
Operating Profit (PBDIT) - Quarterly
Highest at Rs 83.16 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 72.05 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 55.53 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 24.29%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 72.05 cr has Grown at 20.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 59.61 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Here's what is not working for Corona Remedies
Earnings per Share (EPS) - Quarterly
Lowest at Rs 6.74
in the last five quartersMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (Rs)